Impact of Exercise on Mitigating the Cardio-toxic Effects of Adriamycin Among Women Newly Diagnosed With Breast Cancer.

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
This research is being done to determine whether exercise while receiving doxorubicin or Adriamycin chemotherapy for breast cancer can reduce the cardio-toxic effects of this treatment on the heart and improve other outcomes related to cancer such as tumor markers, nausea, fatigue and the ability to tolerate chemotherapy.
Epistemonikos ID: 1ac0712149cafc1cf1693097e504ef5aa4fb24b8
First added on: May 20, 2024